Treatment Delays and Chance of Reperfusion Therapy in Patients with Acute Stroke: A Danish Nationwide Study

Cerebrovasc Dis. 2023;52(3):275-282. doi: 10.1159/000526733. Epub 2022 Oct 31.

Abstract

Introduction: We aimed to determine the treatment delay for ischemic stroke patients in Denmark.

Methods: A nationwide register-based study on acute ischemic stroke patients admitted through emergency medical services. Treatment delay comprised patient, prehospital, and in-hospital delay. Analyses were stratified according to length of prehospital delay (<3 vs. ≥3 h).

Results: A total of 5,356 ischemic stroke episodes were included. The median onset-to-door time was 187 min, and 2,405 (43%) arrived at the stroke unit within 3 h. Overall, the median patient delay was 115 min. For early arrival (n = 2,280), patient delay was 27 min compared to 437 min for late arrivals (n = 2,448). Median prehospital delay varied by 9 min between early- and late-arriving patients. Approximately 48% of the early-arriving patients compared to 9% of the late-arriving patients received i.v. thrombolysis. For thrombectomy, the numbers were 10% and 3%, respectively. This corresponded to an unadjusted relative risk (RR) of 0.18 (95% CI: 0.16-0.21) and adjusted (age, sex, cohabitation status, and stroke severity) RR of 0.20 (95% CI: 0.18-0.23) for i.v. thrombolysis when comparing patients arriving later than 3 h with patients arriving earlier. For thrombectomy, the unadjusted and adjusted RRs were 0.30 (95% CI: 0.23-0.39) and 0.40 (95% CI: 0.31-0.52), respectively.

Conclusions: Patient delay remains the most important barrier for use of reperfusion therapy among acute ischemic stroke patients calling 1-1-2, whereas system delay seems independent of patient delay.

Keywords: Emergency medical services; Onset to treatment; Stroke; Thrombectomy; Thrombolytic therapy; Time factors; Time to treatment.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Denmark
  • Emergency Medical Services*
  • Humans
  • Ischemic Stroke*
  • Reperfusion
  • Stroke* / drug therapy
  • Stroke* / therapy
  • Thrombolytic Therapy / adverse effects
  • Time-to-Treatment
  • Treatment Outcome